BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 6320398)

  • 1. [Should thalidomide be rehabilitated?].
    Belaube P; Garcin G; Marchand JP; Privat Y
    Sem Hop; 1983 Dec; 59(45):3101-4. PubMed ID: 6320398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide--effect on T cell subsets as a possible mechanism of action.
    Moncada B; Baranda ML; González-Amaro R; Urbina R; Loredo CE
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of thalidomide's history and current dermatological applications.
    Perri AJ; Hsu S
    Dermatol Online J; 2003 Aug; 9(3):5. PubMed ID: 12952752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide: a re-look.
    Grover JK; Vats V; Gopalakrishna R; Ramam M
    Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thalidomide in dermatology].
    Hunziker T; Krebs A
    Hautarzt; 1983 Feb; 34(2):66-72. PubMed ID: 6841082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative uses of thalidomide.
    Chen M; Doherty SD; Hsu S
    Dermatol Clin; 2010 Jul; 28(3):577-86. PubMed ID: 20510766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thalidomide: an eclectic medication in dermatology].
    Proença NG
    Rev Paul Med; 1989; 107(1):41-6. PubMed ID: 2694291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide: an experience in therapeutic outcome and adverse reactions.
    Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
    J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.
    Tseng S; Pak G; Washenik K; Pomeranz MK; Shupack JL
    J Am Acad Dermatol; 1996 Dec; 35(6):969-79. PubMed ID: 8959957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide and its dermatologic uses.
    Paghdal KV; Schwartz R
    Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide in leprosy and some dermatological conditions--a review.
    Parikh DA; Maniar JK; Ganapati R
    Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions.
    Barnhill RL; McDougall AC
    J Am Acad Dermatol; 1982 Sep; 7(3):317-23. PubMed ID: 7130490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide: dermatological indications, mechanisms of action and side-effects.
    Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
    Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatologic and nondermatologic uses of thalidomide.
    Nasca MR; Micali G; Cheigh NH; West LE; West DP
    Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thalidomide: a review of the literature].
    dos Santos Júnior MF; Lombardi C; Belda W
    Hansenol Int; 1981 Dec; 6(2):136-45. PubMed ID: 7349301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thalidomide in the treatment of discoid lupus erythematosus (D.L.E.) (author's transl)].
    Samsoen M; Grosshans E; Basset A
    Ann Dermatol Venereol; 1980 Jun; 107(6):515-23. PubMed ID: 7425456
    [No Abstract]   [Full Text] [Related]  

  • 18. Dermatologic therapeutics: thalidomide. A practical guide.
    Rosenbach M; Werth VP
    Dermatol Ther; 2007; 20(4):175-86. PubMed ID: 17970884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The revival of thalidomide: an old drug with new indications].
    Laffitte E
    Rev Prat; 2006 Nov; 56(18):1977-83. PubMed ID: 17274497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo.
    Estrada-G I; Garibay-Escobar A; Núñez-Vázquez A; Hojyo-Tomoka T; Vega-Memije E; Cortés-Franco R; Pérez-Uribe A; Flores-Romo L; Santos-Argumedo L; Estrada-Parra S; Domínguez-Soto L
    Int J Dermatol; 2004 Dec; 43(12):893-7. PubMed ID: 15569010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.